Best Medical Stocks To Add to Your Watchlist – November 6th

Humana, Stryker, Globus Medical, McKesson, HCA Healthcare, Medtronic, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares in companies involved in healthcare, such as pharmaceutical and biotechnology firms, medical-device makers, and healthcare providers. Investors may consider them for exposure to healthcare demand, but their performance can be affected by factors like clinical-trial results, regulation, and patent expirations. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Humana (HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Shares of NYSE HUM traded up $19.47 during mid-day trading on Friday, reaching $431.26. 1,215,025 shares of the company traded hands, compared to its average volume of 1,635,889. Humana has a fifty-two week low of $163.11 and a fifty-two week high of $456.50. The firm has a market cap of $51.79 billion, a PE ratio of 40.79, a price-to-earnings-growth ratio of 2.57 and a beta of 0.65. The stock has a fifty day simple moving average of $403.16 and a 200-day simple moving average of $311.45. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

SYK traded down $10.22 during trading on Friday, reaching $324.86. The stock had a trading volume of 1,292,289 shares, compared to its average volume of 2,501,956. The stock has a 50 day moving average of $292.31 and a two-hundred day moving average of $323.76. The company has a quick ratio of 1.30, a current ratio of 2.18 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $123.67 billion, a price-to-earnings ratio of 34.61, a price-to-earnings-growth ratio of 2.33 and a beta of 0.78. Stryker has a 1-year low of $267.00 and a 1-year high of $389.33.

Globus Medical (GMED)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.

Shares of GMED stock traded down $9.15 during mid-day trading on Friday, hitting $72.29. 4,613,209 shares of the stock traded hands, compared to its average volume of 1,494,003. Globus Medical has a twelve month low of $70.74 and a twelve month high of $101.40. The firm has a market cap of $9.71 billion, a price-to-earnings ratio of 18.57, a price-to-earnings-growth ratio of 1.40 and a beta of 0.98. The company’s 50-day simple moving average is $77.44 and its 200-day simple moving average is $83.29.

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Shares of MCK traded down $6.54 during midday trading on Friday, reaching $1,065.46. The stock had a trading volume of 301,718 shares, compared to its average volume of 917,065. McKesson has a 52 week low of $723.68 and a 52 week high of $1,121.50. The firm’s 50 day moving average price is $934.72 and its 200-day moving average price is $866.92. The company has a market capitalization of $124.22 billion, a P/E ratio of 27.43, a P/E/G ratio of 2.13 and a beta of 0.27.

HCA Healthcare (HCA)

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

HCA stock traded down $11.57 during trading hours on Friday, hitting $495.91. 565,312 shares of the stock traded hands, compared to its average volume of 1,351,498. The stock has a 50-day simple moving average of $442.16 and a 200 day simple moving average of $445.10. The company has a market cap of $103.59 billion, a P/E ratio of 16.45, a P/E/G ratio of 1.71 and a beta of 1.11. HCA Healthcare has a one year low of $353.99 and a one year high of $556.52.

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Shares of NYSE MDT traded down $2.39 during midday trading on Friday, reaching $102.45. The company’s stock had a trading volume of 2,592,157 shares, compared to its average volume of 11,296,015. The company has a current ratio of 2.07, a quick ratio of 1.54 and a debt-to-equity ratio of 0.50. The company has a 50 day moving average price of $92.47 and a 200 day moving average price of $88.43. Medtronic has a one year low of $73.31 and a one year high of $106.33. The company has a market cap of $131.05 billion, a price-to-earnings ratio of 25.25, a price-to-earnings-growth ratio of 2.46 and a beta of 0.56.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

Shares of NASDAQ:GILD traded up $0.10 on Friday, reaching $167.67. 1,520,952 shares of the company traded hands, compared to its average volume of 6,835,318. Gilead Sciences has a fifty-two week low of $116.88 and a fifty-two week high of $176.58. The company’s 50 day moving average is $152.68 and its 200-day moving average is $140.73. The stock has a market capitalization of $207.96 billion, a PE ratio of -53.06 and a beta of 0.35. The company has a debt-to-equity ratio of 1.84, a current ratio of 1.38 and a quick ratio of 0.95.